Oniria Therapeutics

Seed
oniriatherapeutics.com Biotech & Healthcare
Total Funding $1.4M
Latest Round $1.4M Seed
Last Announced May 11, 2023
Investors Undisclosed
Decision Makers 4 Available

About Oniria Therapeutics

Modulating cell dormancy to overcome cancer persistence

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website oniriatherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $1,400,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Oniria Therapeutics.

Funding History

1 Round
Seed equity · May 11, 2023

Founders & Leadership

6

Carlos Galdeano

Co-Founder and Scientific Advisor in drug discovery

Work email & phone locked Unlock →

Esther Riambau

Co-Founder and Chief Executive Officer

Work email & phone locked Unlock →

Héctor G. Palmer

Co-Founder and Chief Scientific Officer

Work email & phone locked Unlock →

Isabel Puig

Co-Founder and Scientific Advisor for new therapeutic targets

Work email & phone locked Unlock →

Josep Tabernero

Co-Founder and Clinical Advisor

Work email & phone locked Unlock →

Xavier Barril

Co-Founder and Scientific Advisor in computational chemistry

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts